US pharmaceutical

AstraZeneca

AstraZeneca chief executive calls for a tax risk

19/05/2014(0)
The US pharmaceutical seeking to acquire UK rival AstraZeneca represents a tax avoidance risk, according to the UK druggist’s chief executive Pascal Soriot. Pfizer, which has proposed a £63bn ... Read More
Broker Cyprus TopFX